Jinling Pharmaceutical Company Limited (SHE:000919)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Medicine Production and Sales	1.49B	1.55B	1.41B	1.48B	1.35B
Medicine Production and Sales Growth	-3.93%	10.24%	-4.64%	9.89%	-1.89%
Medical Services	1.74B	1.57B	1.21B	1.29B	1.12B
Medical Services Growth	10.83%	29.30%	-5.73%	14.68%	-1.27%
Others	48.22M	69.79M	46.95M	42.38M	35.27M
Others Growth	-30.91%	48.64%	10.79%	20.16%	35.78%
Total	3.28B	3.19B	2.67B	2.81B	2.50B
Total Growth	2.74%	19.58%	-4.91%	12.18%	-1.23%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	-	-	-	-	2.50B
China Growth	-	-	-	-	-1.23%
North China	62.35M	21.92M	14.77M	17.62M	-
North China Growth	184.41%	48.46%	-16.22%	-	-
Northwest China	41.36M	11.36M	8.43M	13.80M	-
Northwest China Growth	264.25%	34.77%	-38.94%	-	-
Northeast China	11.40M	16.23M	27.73M	33.06M	-
Northeast China Growth	-29.78%	-41.48%	-16.11%	-	-
Xinjiang Region	2.87M	5.54M	447.23K	1.05M	-
Xinjiang Region Growth	-48.20%	1138.99%	-57.47%	-	-
Central and Southwest China	146.00M	129.81M	105.77M	120.44M	-
Central and Southwest China Growth	12.47%	22.73%	-12.19%	-	-
East China	3.01B	3.01B	2.51B	2.62B	-
East China Growth	0.20%	19.74%	-4.31%	-	-
Overseas	6.30M	3.91M	4.11M	-	-
Overseas Growth	61.17%	-4.99%	-	-	-
Total	3.28B	3.19B	2.67B	2.81B	2.50B
Total Growth	2.74%	19.58%	-4.91%	12.18%	-1.23%

Source: S&P Global Market Intelligence.